Does GLATIRAMER Cause Therapy cessation? 420 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 420 reports of Therapy cessation have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.9% of all adverse event reports for GLATIRAMER.
420
Reports of Therapy cessation with GLATIRAMER
0.9%
of all GLATIRAMER reports
1
Deaths
74
Hospitalizations
How Dangerous Is Therapy cessation From GLATIRAMER?
Of the 420 reports, 1 (0.2%) resulted in death, 74 (17.6%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 420 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which GLATIRAMER Alternatives Have Lower Therapy cessation Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE